S100A1 Antibody 5066S from Cell Signaling Technology

3 Trask Lane

Danvers, Massachusetts 01923

United States

Phone: 877-616-CELL
Phone: 978-867-2388
Fax: 866-432-6112
Fax: 978-867-2488

(1) Long non‑coding RNA FOXD2‑AS1 regulates the�tumorigenesis and progression of breast cancer via the S100 calcium binding protein A1/Hippo signaling pathwayInternational Journal of Molecular MedicineAugust 10, 2020Pei Huang, Jinhui XueMMP9 (1:1,000; cat. no. ab38898; Abcam), S100 calcium binding protein A1 (S100A1; 1:1,000; cat. no. 5066; Cell Signaling Technology, Inc.), phosphorylated (p)-yes-associated protein (YAP; 1:1,000; cat. no.

(4) Partial involvement of Nrf2 in skeletal muscle mitohormesis as an adaptive response to mitochondrial uncouplingScientific reportsFebruary 5, 2018Coleman V, Sa-Nguanmoo P, Koenig J, Schulz TJ, Grune T, Klaus S, Kipp AP, Ost M.

(5) RSL3 Drives Ferroptosis Through GPX4 Inactivation and ROS Production in Colorectal CancerFrontiers in pharmacologyJanuary 1, 2018Sui X, Zhang R, Liu S, Duan T, Zhai L, Zhang M, Han X, Xiang Y, Huang X, Lin H, et al.

(6) The Activation of Protein Kinase A by the Calcium-Binding Protein S100A1 Is Independent of Cyclic AMPBiochemistryMay 2, 2017Zephan Melville et al.(Invitrogen) and transferred to PVDF membranes (EMD Millipore). The S100A1 polyclonal rabbit antibody (1:1000; 5066, Cell Signaling) was used. Blots were incubated with the primary antibody followed by horseradish peroxidase-conjugated

International Journal of Molecular Medicine